Patients as Partners 2022: Moving from Insights to Action

Empowered patients are the touchstone of modern healthcare. Yet, in a highly regulated industry, with scores of stakeholders, novel scientific questions and methodologies, emerging technologies and digital tools, the clinical research community can miss the forest for the trees when it comes to patient empowerment.

Regulatory & Access Resources

Patients as Partners 2022: Moving from Insights to Action

New CNS Franchise Leader brings experience from pharma and as a clinician and researcher

Taking a Proactive, Preventive Approach to Data Privacy in Clinical Documentation

Inclusion for all: Expanding trial accessibility for transgender and nonbinary patients

Including patients in DCT design

Membership in Clinical Research Data Sharing Alliance enables Parexel to shape the future of clinical trial data

SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change

U.S. price reforms 2022: How can drug manufacturers best prepare for the Inflation Reduction Act?

Rachel Smith joins Parexel as Executive Director and Head of the Rare Disease, Center of Excellence

Taking a Proactive Approach to Post-Launch Patient Accessibility in Strategic Planning

Preparing for a new era in European Market Access

Preparing for the New Era of Hybrid Regulatory Inspections

Preparing for the New Era of Hybrid Regulatory Inspections

Parexel names first Patient Ambassador

Mitigating FSP talent shortfalls through development

Adapting drug supply strategies to modern study models

Maintaining Data Integrity for Quality and Compliance – Essential Despite Pandemic Disruptions

New FDA Guidance Addresses the Need for Data-Generation Strategies Across the Drug Development Lifecycle

Patient Advocacy Groups: A vital partner for sponsors that understand how to engage with patients

Toward more inclusive studies: Reaching and retaining patients from underrepresented communities

End-to-end risk management: Getting the most from your program